Recombinant FDFT1 anticorps
Aperçu rapide pour Recombinant FDFT1 anticorps (ABIN7127486)
Antigène
Voir toutes FDFT1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- FDFT1 Recombinant Monoclonal Antibody
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human FDFT1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:5000, IHC:1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- FDFT1 (Farnesyl-Diphosphate Farnesyltransferase 1 (FDFT1))
-
Autre désignation
- FDFT1
-
Sujet
-
Background: endoplasmic reticulum, endoplasmic reticulum membrane, integral component of membrane, farnesyl-diphosphate farnesyltransferase activity, squalene synthase activity, cholesterol biosynthetic process, farnesyl diphosphate metabolic process, regulation of cholesterol biosynthetic process, regulation of lipid metabolic process, steroid biosynthetic process
Aliases: Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase), FDFT1
-
UniProt
- P37268
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-